DRUG-PATHWAY

DRUGs and PATHWAYs

PATHWAY_NAME	REACTOME_ID	KEGG_ID	DRUG_NAME	PUBCHEM_CID	Datasource
Graft-versus-host disease	R-HSA-1643685	map05332	irinotecan	6100671	drug-path
Hematopoietic cell lineage	R-HSA-173752	map04640	irinotecan	6100671	drug-path
PPAR signaling pathway	R-HSA-168638	map03320	irinotecan	6100671	drug-path
Alzheimer's disease	R-HSA-1643685	0	irinotecan	6100671	drug-path
Neuroactive ligand-receptor interaction	R-HSA-5632681	map04080	irinotecan	6100671	drug-path
Autoimmune thyroid disease	R-HSA-1643685	map05320	irinotecan	6100671	drug-path
Antigen processing and presentation	R-HSA-1236975	map04612	irinotecan	6100671	drug-path
Cell adhesion molecules (CAMs)	R-HSA-1031690	0	irinotecan	6100671	drug-path
Cell cycle	R-HSA-1640170	map04110	irinotecan	6100671	drug-path
Primary immunodeficiency	R-HSA-5601905	map05340	irinotecan	6100671	drug-path
Asthma	R-HSA-444620	map05310	irinotecan	6100671	drug-path
ECM-receptor interaction	R-HSA-373711	map04512	irinotecan	6100671	drug-path
Jak-STAT signaling pathway	R-HSA-168638	map04630	irinotecan	6100671	drug-path
Cytokine-cytokine receptor interaction	R-HSA-6788467	map04060	irinotecan	6100671	drug-path
Ribosome	R-HSA-5368277	map03010	irinotecan	6100671	drug-path
Allograft rejection	R-HSA-9679028	map05330	irinotecan	6100671	drug-path
Maturity onset diabetes of the young	R-HSA-5619073	map04950	irinotecan	6100671	drug-path
Type I diabetes mellitus	R-HSA-5683209	map04940	irinotecan	6100671	drug-path
Basal cell carcinoma	R-HSA-5626181	map05217	irinotecan	6100671	drug-path
ABC transporters	R-HSA-1369007	map02010	irinotecan	6100671	drug-path